With the purpose of addressing these agendas, eight main axes of priorities and strategic goals have been defined for Portugal 2030:
- Innovation and Knowledge
- Qualification, Training, and Jobs
- Demographic Sustainability
- Energy and climate changes
- Ocean Economy
- Competitiveness and cohesion of coastal territories
- Competitiveness and cohesion of interior territories
- Agriculture/Forests
With this new program, the European Union hopes to address specific problems of the Portuguese economy, such as an ageing population or a chaotic territorial planning (Portugal is still one of the worst countries in Europe as far as forest fires are concerned), while appealing to the strengths and competitive advantages of this small but very capable country.
Associations such as Vector B2B are at the forefront of the Portuguese scientific and medical research sector. VectorB2B is a clear example of the top tier services that our country offers to the world, contributing to Portugal’s affirmation as a cutting-edge service provider, in an ever-changing world. Specifically, Vector B2B gathers the scattered capabilities of the Portuguese scientific research sector, leading to the accumulation of know-how and the increase in R&D competitiveness internationally, a cornerstone of the European Strategy for countries like Portugal.
As a collaborative laboratory to whom was granted funding from the Portugal 2020 operational program, Vector B2B is the embodiment of the spirit within the whole European Strategy, with a clear emphasys on highly qualified human resources, not just scientific, but in all the other company departments.
Starting up in such a demanding area is extremely hard, which makes European funding a very important part of the project implementation. These funds are critical for the kick-start of companies like Vector B2B, creating the foundations for an effective employment of these highly qualified workers. In the future, such companies will have their full financial independence, while occupying a relevant position in the Portuguese medical research sector and in the national economy as well.
With this strategy, the European Union guarantees that each countries’ specific advantages are explored in the most efficient way and that companies, in smaller countries such as Portugal, can compete with their counterparts in more developed countries.
Bruno Nobre – VectorB2B – Financial & Project Manager